Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma

Clinical trial NCT00445692 · COMPLETED

Trial details

NCT number: NCT00445692
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

DS Stage I Plasma Cell Myeloma DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2007-01-10
Primary completion: 2017-04-24
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.